IRIS Accounts Production v23.4.0.336 03237171 Board of Directors 1.9.22 31.8.23 31.8.23 false true false false true false Fair value model 138453 149895 35959 43600 56240 55042 118172 138453 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh032371712022-08-31032371712023-08-31032371712022-09-012023-08-31032371712021-08-31032371712021-09-012022-08-31032371712022-08-3103237171ns15:EnglandWales2022-09-012023-08-3103237171ns14:PoundSterling2022-09-012023-08-3103237171ns10:Director12022-09-012023-08-3103237171ns10:PrivateLimitedCompanyLtd2022-09-012023-08-3103237171ns10:SmallEntities2022-09-012023-08-3103237171ns10:AuditExempt-NoAccountantsReport2022-09-012023-08-3103237171ns10:SmallCompaniesRegimeForDirectorsReport2022-09-012023-08-3103237171ns10:SmallCompaniesRegimeForAccounts2022-09-012023-08-3103237171ns10:AbridgedAccounts2022-09-012023-08-310323717142ns10:Director22022-08-310323717142ns10:Director22021-08-310323717142ns10:Director22022-09-012023-08-310323717142ns10:Director22021-09-012022-08-310323717142ns10:Director22023-08-310323717142ns10:Director22022-08-3103237171ns10:Director22022-09-012023-08-3103237171ns10:CompanySecretary12022-09-012023-08-3103237171ns10:RegisteredOffice2022-09-012023-08-3103237171ns5:CurrentFinancialInstruments2023-08-3103237171ns5:CurrentFinancialInstruments2022-08-3103237171ns5:ShareCapital2023-08-3103237171ns5:ShareCapital2022-08-3103237171ns5:RevaluationReserve2023-08-3103237171ns5:RevaluationReserve2022-08-3103237171ns5:RetainedEarningsAccumulatedLosses2023-08-3103237171ns5:RetainedEarningsAccumulatedLosses2022-08-3103237171ns5:FurnitureFittings2022-09-012023-08-31032371711ns10:Director12022-08-31032371711ns10:Director12021-08-31032371711ns10:Director12022-09-012023-08-31032371711ns10:Director12021-09-012022-08-31032371711ns10:Director12023-08-31032371711ns10:Director12022-08-31
REGISTERED NUMBER: 03237171 (England and Wales)











B10 MED PROPERTIES LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2023






B10 MED PROPERTIES LIMITED (REGISTERED NUMBER: 03237171)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023










Page

Company Information 1

Abridged Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 6


B10 MED PROPERTIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 AUGUST 2023







DIRECTORS: Mr J D Hayton
Mrs D J Hayton





SECRETARY: Mrs D J Hayton





REGISTERED OFFICE: Heritage House
Murton Way
Osbaldwick
York
North Yorkshire
YO19 5UW





REGISTERED NUMBER: 03237171 (England and Wales)





ACCOUNTANTS: UHY Calvert Smith
Chartered Accountants
Heritage House
Murton Way
Osbaldwick
York
North Yorkshire
YO19 5UW

B10 MED PROPERTIES LIMITED (REGISTERED NUMBER: 03237171)

ABRIDGED BALANCE SHEET
31 AUGUST 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - -
Investment property 5 850,000 850,000
850,000 850,000

CURRENT ASSETS
Debtors 213,747 228,728
Cash at bank 3,659 8,483
217,406 237,211
CREDITORS
Amounts falling due within one year 39,829 44,029
NET CURRENT ASSETS 177,577 193,182
TOTAL ASSETS LESS CURRENT LIABILITIES 1,027,577 1,043,182

PROVISIONS FOR LIABILITIES 41,952 31,863
NET ASSETS 985,625 1,011,319

CAPITAL AND RESERVES
Called up share capital 120 120
Retained earnings
(non-distributable) 443,168 443,168
Retained earnings 542,337 568,031
SHAREHOLDERS' FUNDS 985,625 1,011,319

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

B10 MED PROPERTIES LIMITED (REGISTERED NUMBER: 03237171)

ABRIDGED BALANCE SHEET - continued
31 AUGUST 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 August 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 February 2024 and were signed on its behalf by:





Mr J D Hayton - Director


B10 MED PROPERTIES LIMITED (REGISTERED NUMBER: 03237171)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2023


1. STATUTORY INFORMATION

B10 Med Properties Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents the amount derived from the letting of commercial property.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment, fixtures & fittings - 25% straight line

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

B10 MED PROPERTIES LIMITED (REGISTERED NUMBER: 03237171)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2023


4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 September 2022
and 31 August 2023 618
DEPRECIATION
At 1 September 2022
and 31 August 2023 618
NET BOOK VALUE
At 31 August 2023 -
At 31 August 2022 -

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 September 2022
and 31 August 2023 850,000
NET BOOK VALUE
At 31 August 2023 850,000
At 31 August 2022 850,000

Fair value at 31 August 2023 is represented by:
£   
Valuation in 2012 375,375
Valuation in 2021 100,000
Cost 374,625
850,000

The carrying value of the investment property is considered by the directors to be fair value as at the balance sheet date.

The amount credited to profit and loss account during the year was £nil (2022: £nil).

B10 MED PROPERTIES LIMITED (REGISTERED NUMBER: 03237171)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2023


6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 August 2023 and 31 August 2022:

2023 2022
£    £   
Mr J D Hayton and Mrs D J Hayton
Balance outstanding at start of year 138,453 149,895
Amounts advanced 35,959 43,600
Amounts repaid (56,240 ) (55,042 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 118,172 138,453

Loans to directors were made on an interest free basis with no fixed repayment terms.

7. RELATED PARTY DISCLOSURES

During the year the company paid dividends of £72,000 (2022: £72,000) to its directors and related family trusts.

At the year end the outstanding balance on the company loan was £52,800 (2022: £47,500) to a company connected to the director.